Phenylzinc iodide solution
Product Information
Molecular Formula
C6H5ZnI
Molecular Weight
269.40
Description
Phenylzinc iodide solution is a paramount compound within the biomedical realm and finds extensive application across multifarious domains. Its indispensable role entails facilitating pharmaceutical drug synthesis, focusing notably on combating ailments like cancer and inflammation. Pioneering distinctive attributes, this solution catalyzes chemical reactions with utmost efficiency, thereby harboring immense possibilities for propelling biomedical exploration and fostering pharmaceutical breakthroughs.
Synonyms
phenylzinc iodide; Zinc, iodophenyl-; Phenylzinc iodide, 0.50 M in THF; benzene; iodozinc(1+); Phenylzinc iodide, 0.5M in THF; Phenylzinc iodide 0.5 M in Tetrahydrofuran
IUPAC Name
benzeneiodozinc(1+)
SMILES
C1=CC=[C-]C=C1.[Zn+]I
InChI
InChI=1S/C6H5.HI.Zn/c1-2-4-6-5-3-1/h1-5H1H/q-1+2/p-1
InChI Key
QXXJGZQLPDQOPF-UHFFFAOYSA-M
Flash Point
1.4 °F - closed cup
Density
0.966 g/mL at 25 °C
Storage
2-8°C
Safety Information
Hazards
H225 - H261 - H302 - H315 - H319 - H335 - H351
Precautionary Statement
P210 - P231 + P232 - P280 - P370 + P378 - P402 + P404 - P403 + P235
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
0
Exact Mass
267.87274 g/mol
Monoisotopic Mass
267.87274 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
8
Formal Charge
0
Complexity
100
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2009042900-A1 | 2,4-diaminoquinazolines for spinal muscular atrophy | 2006-08-01 |
| US-2008318976-A1 | Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists | 2003-12-22 |
| US-7790754-B2 | Alpha-hydroxy amides as bradykinin antagonists or inverse agonists | 2003-12-22 |
| US-2005288305-A1 | N-biarylmethyl aminocycloalkanecarboxamide derivatives | 2002-08-29 |
| US-7163951-B2 | N-biarylmethyl aminocycloalkanecarboxamide derivatives | 2002-08-29 |
| US-2004029920-A1 | 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives | 2002-08-06 |
| US-2004034064-A1 | 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives | 2002-08-06 |
| US-2004044041-A1 | 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives | 2002-08-06 |
| US-2004063761-A1 | 2-(biarylalkyl)amino-3-(fluoroalkanoylamino)pyridine derivatives | 2002-08-06 |
| US-2003220375-A1 | N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives | 2002-02-08 |
